Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk - Richard,S; Chari,A; Delimpasi,S; Simonova,M; Spicka,I; Pour,L; Kriachok,I; Dimopoulos,MA; Pylypenko,H; Auner,HW; Leleu,X; Usenko,G; et al. (AMERICAN JOURNAL OF HEMATOLOGY, 2021)